In vitro methods in drug transporter interaction assessment

Drug Discovery Today: Technologies

Volumn 12, Issue , 2014, Pages

  Jani, Márton ^a   Krajcsi, Péter ^a  

^a SOLVO BIOTECHNOLOGY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; DRUG TRANSPORTER PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; ABC TRANSPORTER; DRUG; ORGANIC ANION TRANSPORTER;

ARTICLE; ATPASE ACTIVITY ASSAY; CELL ASSAY; CELL MEMBRANE; CELLULAR EFFLUX ASSAY; CELLULAR UPTAKE ASSAY; DRUG TRANSPORT; HUMAN; IN VITRO STUDY; MOLECULAR INTERACTION; MONOLAYER ASSAY; NONHUMAN; VESICULAR TRANSPORT ASSAY; ANIMAL; ANTAGONISTS AND INHIBITORS; BINDING SITE; BIOASSAY; DRUG DEVELOPMENT; DRUG INTERACTION; ENZYME SPECIFICITY; METABOLISM; PHARMACOKINETICS; PROCEDURES; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BINDING SITES; BIOLOGICAL ASSAY; BIOLOGICAL TRANSPORT; CELL MEMBRANE; DRUG DISCOVERY; DRUG INTERACTIONS; HUMANS; ORGANIC ANION TRANSPORTERS; PHARMACEUTICAL PREPARATIONS; PHARMACOKINETICS; SUBSTRATE SPECIFICITY;

EID: 84901242149     PISSN: None     EISSN: 17406749     Source Type: Journal    
DOI: 10.1016/j.ddtec.2014.03.011     Document Type: Review

References (43)

1. F. Muller, and M.F. Fromm Transporter-mediated drug-drug interactions Pharmacogenomics 12 2011 1017 1037
2. H. Suzuki, and Y. Sugiyama Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine Eur J Pharm Sci 12 2000 3 12
3. I. Tamai, and A. Tsuji Transporter-mediated permeation of drugs across the blood-brain barrier J Pharm Sci 89 2000 1371 1388
4. B. Feng, J.L. LaPerle, G. Chang, and M.V. Varma Renal clearance in drug discovery and development: molecular descriptors, drug transporters and disease state Expert Opin Drug Metab Toxicol 6 2010 939 952
5. P. Chandra, and K.L. Brouwer The complexities of hepatic drug transport: current knowledge and emerging concepts Pharm Res 21 2004 719 735
6. O. Zolk, and M.F. Fromm Transporter-mediated drug uptake and efflux: important determinants of adverse drug reactions Clin Pharmacol Ther 89 2011 798 805
7. International Transporter Consortium, K.M. Giacomini, S.M. Huang, D.J. Tweedie, L.Z. Benet, and K.L. Brouwer et al. Membrane transporters in drug development Nat Rev Drug Discov 9 2010 215 236
8. L. Zhang, S.M. Huang, and L.J. Lesko Transporter-mediated drug-drug interactions Clin Pharmacol Ther 89 2011 481 484
9. M. Honorat, P. Falson, R. Terreux, A. Di Pietro, C. Dumontet, and L. Payen Multidrug resistance ABC transporter structure predictions by homology modeling approaches Curr Drug Metab 12 2011 268 277
10. H. Glavinas, E. Kis, A. Pál, R. Kovács, M. Jani, and E. Vági et al. ABCG2 (breast cancer resistance protein/mitoxantrone resistance-associated protein) ATPase assay: a useful tool to detect drug-transporter interactions Drug Metab Dispos 35 2007 1533 1542
11. ++ by sarcoplasmic reticulum fragments J Biol Chem 239 1964 648 658
12. T.L. Steck, R.S. Weinstein, J.H. Straus, and D.F. Wallach Inside-out red cell membrane vesicles: preparation and purification Science 168 1970 255 257
13. R.L. Juliano, and V. Ling A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants Biochim Biophys Acta 455 1976 152 162
14. M. Horio, M.M. Gottesman, and I. Pastan ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells Proc Natl Acad Sci U S A 85 1988 3580 3584
15. B. Sarkadi, E.M. Price, R.C. Boucher, U.A. Germann, and G.A. Scarborough Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase J Biol Chem 267 1992 4854 4858
16. C.A. Doige, and F.J. Sharom Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells Biochim Biophys Acta 1109 1992 161 171
17. F.J. Sharom, X. Yu, P. Lu, R. Liu, J.W. Chu, and K. Szabó et al. Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells Biochem Pharmacol 58 1999 571 586
18. B. Stieger, K. Fattinger, J. Madon, G.A. Kullak-Ublick, and P.J. Meier Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver Gastroenterology 118 2000 422 430
19. G. Williamson, I. Aeberli, L. Miguet, Z. Zhang, M.B. Sanchez, and V. Crespy et al. Interaction of positional isomers of quercetin glucuronides with the transporter ABCC2 (cMOAT, MRP2) Drug Metab Dispos 35 2007 1262 1268
20. M.K. Al-Shawi, M.K. Polar, H. Omote, and R.A. Figler Transition state analysis of the coupling of drug transport to ATP hydrolysis by P-glycoprotein J Biol Chem 278 2003 52629 52640
21. Y. Shirasaka, Y. Onishi, A. Sakurai, H. Nakagawa, T. Ishikawa, and S. Yamashita Evaluation of human P-glycoprotein (MDR1/ABCB1) ATPase activity assay method by comparing with in vitro transport measurements: Michaelis-Menten kinetic analysis to estimate the affinity of P-glycoprotein to drugs Biol Pharm Bull 29 2006 2465 2471
22. H. Goldberg, V. Ling, P.Y. Wong, and K. Skorecki Reduced cyclosporin accumulation in multidrug-resistant cells Biochem Biophys Res Commun 152 1988 552 558
23. H. Glavinas, D. Mehn, M. Jani, B. Oosterhuis, K. Herédi- Szabó, and P. Krajcsi Utilization of membrane vesicle preparations to study drug-ABC transporter interactions Expert Opin Drug Metab Toxicol 4 2008 721 732
24. A. Pal, D. Mehn, E. Molnár, S. Gedey, P. Mészáros, and T. Nagy et al. Cholesterol potentiates ABCG2 activity in a heterologous expression system: improved in vitro model to study function of human ABCG2 J Pharmacol Exp Ther 321 2007 1085 1094
25. E. Kis, E. Ioja, T. Nagy, L. Szente, K. Herédi-Szabó, and P. Krajcsi Effect of membrane cholesterol on BSEP/Bsep activity: species specificity studies for substrates and inhibitors Drug Metab Dispos 37 2009 1878 1886
26. G.E. Flaten, G. Kottra, W. Stensen, G. Isaksen, R. Karstad, and J.S. Svendsen et al. In vitro characterization of human peptide transporter hPEPT1 interactions and passive permeation studies of short cationic antimicrobial peptides J Med Chem 54 2011 2422 2432
27. +/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2 J Am Soc Nephrol 17 2006 2127 2135
28. T. De Bruyn, Z.W. Ye, A. Peeters, J. Sahi, M. Baes, and P.F. Augustijns et al. Determination of OATP-, NTCP- and OCT-mediated substrate uptake activities in individual and pooled batches of cryopreserved human hepatocytes Eur J Pharm Sci 43 2011 297 307
29. A.R. Erdman, L.M. Mangravite, T.J. Urban, L.L. Lagpacan, R.A. Castro, and M. de la Cruz et al. The human organic anion transporter 3 (OAT3; SLC22A8): genetic variation and functional genomics Am J Physiol Renal Physiol 290 2006 F905 F912
30. G. Szakács, K. Jakab, F. Antal, and B. Sarkadi Diagnostics of multidrug resistance in cancer Pathol Oncol Res 4 1994 251 257
31. M. Ogura, M. Ayaori, Y. Terao, T. Hisada, M. Iizuka, and S. Takiguchi et al. Proteasomal inhibition promotes ATP-binding cassette transporter A1 (ABCA1) and ABCG1 expression and cholesterol efflux from macrophages in vitro and in vivo? Arterioscler Thromb Vasc Biol 31 2011 1980 1987
32. H. Lennernas, S. Nylander, and A.L. Ungell Jejunal permeability: a comparison between the Ussing chamber technique and the single-pass perfusion in humans Pharm Res 14 1997 667 671
33. R. Elsby, D.D. Surry, V.N. Smith, and A.J. Gray Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions Xenobiotica 38 7-8 2008 1140 1164
34. P. Artursson Epithelial transport of drugs in cell culture. I: A model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells J Pharm Sci 79 6 1990 476 482
35. R.B. van Breemen, and Y. Li Caco-2 cell permeability assays to measure drug absorption Expert Opin Drug Metab Toxicol 1 2 2005 175 185
36. K. Kopplow, K. Letschert, J. König, B. Walter, and D. Keppler Human hepatobiliary transport of organic anions analyzed by quadruple-transfected cells Mol Pharmacol 68 4 2005 1031 1038
37. J. Konig, O. Zolk, K. Singer, C. Hoffmann, and M.F. Fromm Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations Br J Pharmacol 163 3 2011 546 555
38. S. Matsushima, K. Maeda, C. Kondo, M. Hirano, H. Sasaki, and H. Suzuki et al. Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein J Pharmacol Exp Ther 314 3 2005 1059 1067
39. J.I. Pachot, R.P. Botham, and K.D. Haegele Experimental estimation of the role of P-glycoprotein in the pharmacokinetic behaviour of telithromycin, a novel ketolide, in comparison with roxithromycin and other macrolides using the Caco-2 cell model J Pharm Pharm Sci 6 1 2003 1 12
40. C. Luna-Tortós, M. Fedrowitz, and W. Löscher Several major antiepileptic drugs are substrates for human P-glycoprotein Neuropharmacology 55 8 2008 1364 1375
41. N. Zelcer, M.T. Huisman, G. Reid, P. Wielinga, P. Breedveld, and A. Kuil et al. Evidence for two interacting ligand binding sites in human multidrug resistance protein 2 (ATP binding cassette C2) J Biol Chem 278 26 2003 23538 23544
42. K. Heredi-Szabo, K. Jemnitz, E. Kis, E. Ioja, J. Jánossy, and L. Vereczkey et al. Potentiation of MRP2/Mrp2-mediated estradiol-17beta-glucuronide transport by drugs - a concise review Chem Biodivers 6 11 2009 1970 1974
43. O. von Richter, H. Glavinas, P. Krajcsi, S. Liehner, B. Siewert, and K. Zech A novel screening strategy to identify ABCB1 substrates and inhibitors Naunyn Schmiedebergs Arch Pharmacol 379 1 2009 11 26